RSRoss Smith

Ross Smith

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ross Smith has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • NMR structure of a concatemer of the first and second ligand‐binding modules of the human low‐density lipoprotein receptor

    by Nyoman D. Kurniawan, Annette R. Atkins, Stephan Bieri, Catherine J. Brown, Paulus A. Kroon, Ross Smith, Ian M. Brereton

    The ligand‐binding domain of the human low‐density lipoprotein receptor consists of seven modules, each of 40–45 residues. In the presence of calcium, these modules adopt a common polypeptide fold with three conserved disulfide bonds. A concatemer of the first and second modules (LB1‐2) folds efficiently in the presence of calcium ions, forming the same disulfide connectivities as in the isolated modules. The three‐dimensional structure of LB1‐2 has now been solved using two‐dimensional 1H NMR spectroscopy and restrained molecular dynamics calculations. No intermodule nuclear Overhauser effects were observed, indicating the absence of persistent interaction between them. The near random‐coil NH and Hα chemical shifts and the low ϕ and ψ angle order parameters of the four‐residue linker suggest that it has considerable flexibility. The family of LB1‐2 structures superimposed well over LB1 or LB2, but not over both modules simultaneously. LB1 and LB2 have a similar pattern of calcium ligands, but the orientations of the indole rings of the tryptophan residues W23 and W66 differ, with the latter limiting solvent access to the calcium ion. From these studies, it appears that although most of the modules in the ligand‐binding region of the receptor are joined by short segments, these linkers may impart considerable flexibility on this region.


  • Open Access

    NMR studies of the low-density lipoprotein receptor-binding peptide of apolipoprotein E bound to dodecylphosphocholine micelles

    by Daniel Clayton, Ian M. Brereton, Paulus A. Kroon, Ross Smith

    Circular dichroism and NMR spectroscopy have been used to determine the structure of the low-density lipoprotein (LDL) receptor-binding peptide, comprising residues 130-152, of the human apolipoprotein E. This peptide has little persistent three-dimensional structure in solution, but when bound to micelles of dodecylphosphocholine (DPC) it adopts a predominantly alpha-helical structure. The three-dimensional structure of the DPC-bound peptide has been determined by using 1H-NMR spectroscopy: the structure derived from NOE-based distance constraints and restrained molecular dynamics is largely helical. The derived phi and psi angle order parameters show that the helical structure is well defined but with some flexibility that causes the structures not to be superimposable over the full peptide length. Deuterium exchange experiments suggest that many peptide amide groups are readily accessible to the solvent, but those associated with hydrophobic residues exchange more slowly, and this helix is thus likely to be positioned on the surface of the DPC micelles. In this conformation the peptide has one hydrophobic face and two that are rich in basic amino acid side chains. The solvent-exposed face of the peptide contains residues previously shown to be involved in binding to the LDL receptor.


  • Ionization states of the catalytic residues in HIV-1 protease

    by Ross Smith, Ian M. Brereton, Richard Y. Chai, Stephen B.H. Kent

    Chemical synthesis was used to prepare the HIV-1 protease specifically 13C-labelled in the catalytically essential Asp 25 in each monomer. The NMR chemical shift of the 13C-enriched homodimeric enzyme was measured in the presence of the inhibitor pepstatin, a mimic of the tetrahedral intermediate formed in enzyme catalysis. In this complex, the catalytic carboxyls do not titrate in the pH range where the enzyme is active; throughout the range pH 2.5–6.5, one Asp 25 side chain is protonated and the other deprotonated. By contrast, in the absence of inhibitor the two Asp side chains are chemically equivalent and both deprotonated at pH 6, the optimum for enzymatic activity. These direct observations of the chemical properties of the catalytic apparatus of the enzyme provide concrete information on which to base the design of improved HIV-1 protease inhibitors.


  • A Deletion in the First Cysteine‐Rich Repeat of the Low‐Density‐Lipoprotein Receptor Leads to the Formation of Multiple Misfolded Isomers

    by Julianne T. Djordjevic, Stephan Bieri, Ross Smith, Paulus A. Kroon

    The ligand‐binding domain of the low‐density‐lipoprotein (LDL) receptor comprises seven cysteine‐rich repeats, each approximately 40 amino acids long. The deletion of two amino acids (Asp26 and Gly27) from the first of these repeats (LB1), leads to a defective LDL receptor, and the clinical syndrome of familial hypercholesterolemia [Leitersdorf, E., Hobbs, H. H., Fourie, A. M., Jacobs, M., van der Westhuyzen, D. R. & Coetzee, G. A. (1988) Proc. Natl Acad. Sci. USA 85, 7912–7916]. Receptors which reach the cell surface fail to bind IgG‐C7, a conformation‐specific monoclonal antibody directed to LB1. To determine the effects of the two‐amino‐acid deletion on the folding of the LB1 of the LDL receptor, we have expressed LBI and the mutant repeat, des‐Asp26, Gly27‐LB1, as recombinant (rLB1 and des‐Asp26, Gly27‐rLB1) peptides, and have determined their ability to fold in vitro. Unlike rLB1, which folded into a single isomer that was recognized by IgG‐C7 and had three disulfide bonds, des‐Asp26, Gly27‐rLB1 folded into an equilibrium mixture of four isomers. Each of these isomers contained three disulfide bonds, but none were recognized by IgG‐C7. We suggest that mutant LDL receptors in the endoplasmic reticulum (ER) of the cell also fold into an equilibrium mixture of distinct receptor molecules, each with an abnormally folded isomer of des‐Asp26, Gly27‐LB1, and that the retarded transport of receptors to the cell surface arises because only a subset of the isomers reaches the cell surface.


  • Expression and disulfide‐bond connectivity of the second ligand‐binding repeat of the human LDL receptor

    by Stephan Bieri, Julianne T. Djordjevic, Negar Jamshidi, Ross Smith, Paulus A. Kroon

    The human LDL receptor (LDLR) has a binding domain which consists of seven contiguous ligand‐binding (LB) repeats, each ∼40 amino acids long with three disulfide bonds. The second LB repeat, which is required for full binding of LDL, has been expressed, purified and folded to yield a single, fully oxidized isomer. By selective reduction and alkylation, we have shown that the cysteine residues have a I–III, II–V, IV–VI connectivity, matching that recently determined for the amino‐terminal repeat. We suggest that the first two LB repeats of the LDLR, with their unique disulfide‐bonding pattern, serve as a structural paradigm for other LB repeats.